Progress of drug resistance mechanism in checkpoint inhibitors / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 780-784, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-712903
ABSTRACT
Immune checkpoint signaling pathway mediates tumor immune escape through various mechanisms. In recent years, studies on immune checkpoint inhibitors have made great breakthroughs in various tumors. However, characteristics of the tumor cells, abnormal presentation of the antigens, functional gene mutations, tumor immune microenvironment, internal environment of patients and metabolic factors can all lead to primary or secondary resistance to immunotherapy. The exploration of the molecular mechanism and response strategy of immunotherapy is the key to further expand the beneficial population treated by immune checkpoint inhibitors and realize the accurate treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS